| P2093 | author name string | Ahmet Gurakar | |
| | Nicolas Jabbour | |
| | Cemalettin Camci | |
| | Sharad Sharma | |
| P2860 | cites work | Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients | Q24245848 |
| | Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications | Q24542134 |
| | The dynamics of human cytomegalovirus replication in vivo | Q28141142 |
| | Eversion thrombectomy for portal vein thrombosis during liver transplantation | Q28194434 |
| | Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data | Q31968983 |
| | Reconstructive surgery for ischemic-type lesions at the bile duct bifurcation after liver transplantation | Q77922728 |
| | Colorectal disease in liver allograft recipients -- a clinicopathological study with follow-up | Q77939941 |
| | Rapid progression to high-grade dysplasia in Barrett's esophagus after liver transplantation | Q77943886 |
| | Gastrointestinal bleeding after living-related liver transplantation | Q78575253 |
| | Consequences of living-donor liver transplantation for upper gastrointestinal lesions: high incidence of reflux esophagitis | Q79197379 |
| | Five cases of de novo inflammatory bowel disease after orthotopic liver transplantation | Q79765279 |
| | Safety of duct-to-duct biliary reconstruction in right-lobe live-donor liver transplantation without biliary drainage | Q79777393 |
| | Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis | Q79834757 |
| | Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel | Q80109260 |
| | Biliary strictures following liver transplantation: past, present and preventive strategies | Q81349496 |
| | De Novo neoplasia after liver transplantation: an analysis of risk factors and influence on survival | Q81359857 |
| | Portal vein thrombosis | Q81476725 |
| | Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience | Q81507567 |
| | Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching | Q82108772 |
| | Long-term outcome of endoscopic treatment of biliary strictures after liver transplantation | Q82571171 |
| | Myeloma, Hodgkin disease, and lymphoid leukemia after renal transplantation: characteristics, risk factors and prognosis | Q82996536 |
| | Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course | Q83062052 |
| | Inflammatory bowel disease after liver transplantation: risk factors for recurrence and de novo disease | Q83314680 |
| | Percutaneous transhepatic thrombolysis in the treatment of acute portal venous thrombosis | Q83921705 |
| | Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. | Q33183542 |
| | Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile | Q33183738 |
| | Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients | Q33243379 |
| | Ganciclovir: an update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients | Q33338232 |
| | Unusual manifestations of primary cytomegalovirus infection in patients without HIV infection and without organ transplants | Q33344063 |
| | Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease | Q33363887 |
| | Nosocomial fungal infections: candidemia | Q33685839 |
| | De novo malignancies following liver transplantation: a case-control study with long-term follow-up | Q33730925 |
| | Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy | Q34033598 |
| | Gastrointestinal malignancy in patients with AIDS. | Q34110010 |
| | Post-transplant biliary problems | Q34139699 |
| | Extrahepatic complications of liver transplantation | Q34201638 |
| | Expression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease | Q34207259 |
| | Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis | Q34247700 |
| | Gastrointestinal bleeding after liver transplantation | Q34247898 |
| | Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis | Q34248909 |
| | Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease | Q34275907 |
| | Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy | Q34330594 |
| | Clostridium difficile: clinical considerations. | Q34373464 |
| | Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years | Q34392483 |
| | Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease | Q34394229 |
| | Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. | Q34427085 |
| | Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. | Q34460156 |
| | Infection in organ-transplant recipients | Q34471508 |
| | Clinical practice. Antibiotic-associated diarrhea | Q34512995 |
| | Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile | Q34530913 |
| | Portal vein thrombosis: a concise review | Q34581409 |
| | Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment | Q34734528 |
| | Incidence and clinical characteristics of Kaposi sarcoma after solid organ transplantation in Spain: importance of seroconversion against HHV-8. | Q34778415 |
| | Inflammatory bowel disease: new insights into pathogenesis and treatment | Q35020743 |
| | Clostridium difficile-associated diarrhea after living donor liver transplantation. | Q35055941 |
| | Skin cancers after organ transplantation | Q35113533 |
| | Fungal infections in the recipients of solid organ transplantation | Q35129031 |
| | Colon carcinoma in patients undergoing liver transplantation | Q77424601 |
| | Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy | Q77571232 |
| | Kaposi's sarcoma after renal transplantation | Q77602630 |
| | Post-liver transplant Crohn's disease: graft tolerance but not self-tolerance? | Q77813813 |
| | Post-transplantation lymphoproliferative disorders localizing to the gastrointestinal tract after liver transplantation: report of five pediatric cases | Q43988028 |
| | Esophageal and gastric Kaposi's sarcomas presenting as upper gastrointestinal bleeding. | Q44079281 |
| | Delayed wound healing with sirolimus after liver transplant | Q44114535 |
| | Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease | Q44116598 |
| | Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience | Q44170861 |
| | Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of HLA-DR matching | Q44321475 |
| | Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion | Q44347307 |
| | Inflammatory bowel disease after liver transplantation: the effect of different immunosuppressive regimens | Q44505156 |
| | Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease | Q44536957 |
| | Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment | Q44609110 |
| | Lichenoid graft vs. host disease following liver transplantation | Q44702853 |
| | Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: comparison of two dosage regimens | Q44770189 |
| | Following universal prophylaxis with intravenous ganciclovir and cytomegalovirus immune globulin, valganciclovir is safe and effective for prevention of CMV infection following lung transplantation | Q45058851 |
| | Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation | Q45073001 |
| | Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome | Q45116890 |
| | Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis | Q45196853 |
| | Cytomegalovirus prophylaxis using oral ganciclovir or valganciclovir in kidney and pancreas-kidney transplantation under antibody preconditioning | Q45248079 |
| | Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis. | Q45289722 |
| | Gastrointestinal hemorrhage due to complicated gastroduodenal ulcer disease in liver transplant patients taking sirolimus | Q45289890 |
| | Posttransplantation lymphoproliferative disorder--the great mimic in liver transplantation: appraisal of the clinicopathologic spectrum and the role of Epstein-Barr virus | Q45403442 |
| | Quantification of Epstein-Barr virus load in Argentinean transplant recipients using real-time PCR. | Q45606390 |
| | The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients | Q45620639 |
| | Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients | Q45722404 |
| | Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients | Q45728579 |
| | Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients | Q45738452 |
| | Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. | Q45739449 |
| | Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? | Q45743876 |
| | Prospective longitudinal analysis of quantitative Epstein-Barr virus polymerase chain reaction in pediatric liver transplant recipients | Q45749815 |
| | Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients. | Q45751844 |
| | Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms | Q45765774 |
| | Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients | Q45780931 |
| | Epstein-Barr virus--determined clonality in posttransplant lymphoproliferative disease. | Q45851296 |
| | Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. | Q45980203 |
| | A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. | Q46408982 |
| | Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. | Q46722604 |
| | Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression | Q46825318 |
| | Biliary complications and outcomes of liver transplantation from donors after cardiac death | Q46877630 |
| | Biliary complications after duct-to-duct biliary reconstruction in living-donor liver transplantation: causes and treatment | Q46988764 |
| | Reversible hepatofugal portal flow after liver transplantation using a small-for-size graft from a living donor | Q47204038 |
| | Impact of evolving trends in recipient and donor characteristics on cytomegalovirus infection in liver transplant recipients | Q47264867 |
| | A role of Helicobacter pylori infection in the development of duodenal ulcer after adult living-related liver transplantation | Q47627058 |
| | Severe Clostridium difficile colitis | Q47645117 |
| | Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis | Q47785131 |
| | Management of biliary stricture guided by the Spyglass Direct Visualization System in a liver transplant recipient: an innovative approach | Q47879958 |
| | CC chemokine receptor 5delta32 polymorphism-a risk factor for ischemic-type biliary lesions following orthotopic liver transplantation | Q47990106 |
| | Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? | Q49033173 |
| | Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. | Q50629106 |
| | CMV-viraemia during allogenic bone marrow transplantation in paediatric patients: association with survival and graft-versus-host disease. | Q50755083 |
| | Percutaneous transhepatic portography for the treatment of early portal vein thrombosis after surgery. | Q50776057 |
| | SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video). | Q51016352 |
| | Endoscopic treatment of biliary complications after right-lobe living-donor liver transplantation with duct-to-duct biliary anastomosis. | Q51098977 |
| | Cytomegalovirus infection following liver transplantation: review of the literature | Q40947383 |
| | Fungal infections in solid organ transplant recipients. | Q41070712 |
| | Chemotherapy of AIDS--related Kaposi's sarcoma | Q41175512 |
| | Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. | Q41198290 |
| | Kaposi's sarcoma in transplant recipients | Q41602450 |
| | Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination | Q41625214 |
| | The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation | Q41646178 |
| | Transplanting the genetic susceptibility to Crohn's disease | Q43005380 |
| | Complications of venous reconstruction in human orthotopic liver transplantation | Q43511518 |
| | Modulation of acid secretion in common bile duct ligation-related gastropathy in Wistar rats | Q43669345 |
| | Idiopathic colitis following cardiac transplantation: three pediatric cases | Q43720798 |
| | Kaposi's sarcoma in liver transplant recipients: morphological and clinical description | Q43734165 |
| | Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study | Q43915265 |
| | Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease | Q43936463 |
| | Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis | Q35352934 |
| | Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion | Q35364870 |
| | Experience with hystidine tryptophan ketoglutarate versus University Wisconsin preservation solutions in transplantation | Q35570783 |
| | Ganciclovir in solid organ transplant recipients: is there a role for clinical pharmacokinetic monitoring? | Q35641915 |
| | Acute graft versus host disease following liver transplantation: the enemy within | Q35691919 |
| | Lymphoproliferative disorders after liver transplantation | Q35749906 |
| | Malignancy in renal transplantation | Q35778329 |
| | The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression | Q35818660 |
| | Post transplant T-cell lymphoma: a case series of four patients from a single unit and review of the literature. | Q35861540 |
| | Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up | Q35990865 |
| | Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis | Q36043646 |
| | Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease | Q36056597 |
| | The impact of early cytomegalovirus infection and disease in renal transplant recipients | Q36168599 |
| | Portal vein thrombosis: etiology, diagnostic strategy, therapy and management | Q36169612 |
| | Diarrhea in liver transplant recipients: etiology and management | Q36202512 |
| | Treatment of Clostridium difficile-associated disease: old therapies and new strategies | Q36240849 |
| | "Will all liver transplantation patients eventually die from cancer?". | Q36317242 |
| | Esophageal squamous cell carcinoma after liver transplantation | Q36350683 |
| | Primary cutaneous T-cell lymphoma occurring after organ transplantation | Q36425042 |
| | Fungal infections complicating orthotopic liver transplantation | Q36647177 |
| | Cancer risk following organ transplantation: a nationwide cohort study in Sweden | Q36671140 |
| | Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression | Q36825746 |
| | Invasive fungal infections and antifungal therapies in solid organ transplant recipients. | Q36872848 |
| | Graft vs. host disease after liver transplantation: a new approach is needed | Q36896559 |
| | A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease | Q38475648 |
| | Long-term incidence, risk factors, and management of biliary complications after adult living donor liver transplantation | Q38510841 |
| | The diagnosis and treatment of posttransplant lymphoproliferative disorders | Q39554794 |
| | Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea | Q39636517 |
| | Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. | Q40224029 |
| | Biliary strictures in 130 consecutive right lobe living donor liver transplant recipients: results of a Western center | Q40251256 |
| | Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies | Q40436819 |
| | Long-Term Infectious Complications of Liver Transplantation | Q40474047 |
| | Use of short tandem repeats for DNA fingerprinting to rapidly diagnose graft-versus-host disease in solid organ transplant patients | Q40488304 |
| | Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism | Q40493276 |
| | Rash and pancytopenia as initial manifestations of acute graft-versus-host disease after liver transplantation | Q40509691 |
| | Posttransplantation lymphoproliferative disorder in pediatric liver transplantation | Q40520401 |
| | The problem of cancer in organ transplant recipients: an overview | Q40558831 |
| | Liver transplant-associated graft-versus-host disease | Q40566893 |
| | Significance of serial real-time PCR monitoring of EBV genome load in living donor liver transplantation | Q40584058 |
| | Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients | Q40602356 |
| | Endoscopic therapy of anastomotic bile duct strictures occurring after liver transplantation | Q40626997 |
| | Esophageal infections: risk factors, presentation, diagnosis, and treatment. | Q40643812 |
| | Clostridium difficile colitis | Q40679117 |
| | Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair | Q40747843 |
| | Long-Term Outcomes for Patients with Post–Liver Transplant Anastomotic Biliary Strictures Treated by Endoscopic Stent Placement | Q51816168 |
| | Venous complications after orthotopic liver transplantation. | Q52971834 |
| | Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. | Q53356778 |
| | Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. | Q54246301 |
| | Gastrointestinal Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Endoscopic and autopsy findings. | Q54331038 |
| | Characteristic Pattern of Chromosomal Imbalances in Posttransplantation Lymphoproliferative Disorders: Correlation with Histopathological Subcategories and EBV Status | Q57218437 |
| | Kaposi's sarcoma of internal organs. A multiparameter study of 86 cases | Q57385863 |
| | Surgical management of necrotizing Candida esophagitis | Q60143428 |
| | Viral Infection in the Renal Transplant Recipient | Q60221213 |
| | Clostridium difficile-Associated Diarrhea and Colitis | Q60362148 |
| | Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease | Q63197317 |
| | Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicenter, case-controlled study1 | Q63859739 |
| | Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression | Q68267663 |
| | Cancers complicating organ transplantation | Q68613885 |
| | Infections in liver transplant recipients | Q70971228 |
| | Colonoscopy in the diagnosis of antibiotic-associated colitis. A prospective study | Q71054866 |
| | Esophageal malignancy after liver transplantation in a patient with Barrett's esophagus | Q71309919 |
| | Complete lymphoid chimerism and chronic graft-versus-host disease in an infant recipient of a hepatic allograft from an HLA-homozygous parental living donor | Q71869696 |
| | Pretransplantation assessment of the risk of lymphoproliferative disorder | Q71910946 |
| | Fluconazole vs itraconazole-flucytosine association in the treatment of esophageal candidiasis in AIDS patients. A double-blind, multicenter placebo-controlled study. The Candida Esophagitis Multicenter Italian Study (CEMIS) Group | Q71958187 |
| | Esophageal candidiasis after renal transplantation: comparative study in patients on different immunosuppressive protocols | Q72028893 |
| | Risk of recurrence of gastric ulcer, chronic gastritis, and grade of Helicobacter pylori colonization. A long-term follow-up study of 25 patients | Q72170532 |
| | Major gastrointestinal bleeding occurring after liver transplantation | Q72261780 |
| | Phenotypic and immunoregulatory analysis of intestinal T-cells in patients with inflammatory bowel disease: evaluation of an in vitro model | Q72314187 |
| | Assessment of histopathologic changes in the colonic biopsy in acute graft-versus-host disease | Q72324318 |
| | Intrahepatic biliary strictures after liver transplantation | Q72421841 |
| | Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology | Q72705542 |
| | The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation | Q72747680 |
| | Vascular complications in a series of 300 orthotopic liver transplants | Q73027622 |
| | Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage | Q73030069 |
| | Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings | Q73117411 |
| | Changes in hepatic portal resistance and in liver morphology during regeneration: in vitro study in rats | Q73362308 |
| | Increased cancer risk after liver transplantation: a population-based study | Q73521178 |
| | Postransplant lymphoproliferative disorder localized near the allograft in renal transplantation | Q73648766 |
| | The influence of donor age to graft volume increase rate in living donor liver transplantation | Q73669036 |
| | High incidence of noninfectious esophagitis in orthotopic liver transplant (OLT) recipients | Q73713795 |
| | [Autoimmune hemolytic anemia and chronic giant cell hepatitis] | Q73820343 |
| | Posttransplantation de novo tumors in liver allograft recipients | Q73824100 |
| | Clinical course and management of inflammatory bowel disease after liver transplantation | Q74250350 |
| | Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis | Q74464487 |
| | Percutaneous thrombolysis and stent placement for the treatment of portal vein thrombosis after liver transplantation: long-term follow-up | Q74535266 |
| | Biliary anastomotic complications in 400 living related liver transplantations | Q74612291 |
| | Acute portal vein thrombosis secondary to donor/recipient portal vein diameter mismatch after orthotopic liver transplantation: a case report | Q75241521 |
| | Cytomegalovirus infection in patients with inflammatory bowel disease | Q77319026 |
| | Diarrhea and Clostridium difficile infection in Latin American patients with AIDS. Working Group on AIDS in Peru | Q77402942 |
| P433 | issue | 7 | |
| P921 | main subject | liver transplantation | Q1368191 |
| P304 | page(s) | 1386-1402 | |
| P577 | publication date | 2008-12-17 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Avoiding pitfalls: what an endoscopist should know in liver transplantation--part II. | |
| P478 | volume | 54 | |